iCre recombinase expressed in the anti-Müllerian hormone receptor 2 gene causes global genetic modification in the mouse
Open Access
- 31 January 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 108 (4) , 575-583
Abstract
Genetically engineered mice are widely used to study the impact of altered gene expression in vivo. Within the reproductive tract, the Amhr2-IRES-Cre(Bhr) mouse model is used to ablate genes in ovarian granulosa and uterine stromal cells. There are reports of Amhr2-IRES-Cre(Bhr) inducing recombination in non-target tissues. We hypothesized the inefficiency or off-target Cre action in Amhr2-IRES-Cre(Bhr) mice is due to lack of recombination in every cell that expresses Amhr2. To investigate, we created a new targeted knock-in mouse model, Amhr2-iCre(Fjd), by inserting a codon-optimized improved Cre (iCre) into exon 1 of the Amhr2 gene. Amhr2-iCre(Fjd)/+ males were mated with females that contain a lox-stop-lox cassette in the Sun1 gene so when DNA recombination occurs, SUN1-sfGFP fusion protein is expressed in a peri-nuclear pattern. In adult Amhr2-iCre(Fjd)/+ Sun1LsL/+ mice, Amhr2-iCre(Fjd)-mediated genetic recombination was apparent in uterine epithelial, stromal, and myometrial cells, while Amhr2-IRES-Cre(Bhr)/+ Sun1LsL/+ females demonstrated inter-mouse variability of Amhr2-IRES-Cre(Bhr) activity in uterine cells. Fluorescence was observed in Amhr2-iCre(Fjd)-positive mice at post-natal Day 1, indicating global genetic recombination, while fluorescence of individual Amhr2-IRES-Cre(Bhr)-positive pups varied. To determine the developmental stage that genetic recombination first occurs, Sun1LsL/LsL females were super-ovulated and mated with Amhr2-IRES-Cre(Bhr)/+ or Amhr2(iCre/+)Fjd males, then putative zygotes were collected and cultured. In the four-cell embryo, Amhr2-iCre(Fjd) and Amhr2-IRES-Cre(Bhr) activities were apparent in 100% and 25–100% of cells, respectively. In conclusion, Amhr2-IRES-Cre(Bhr) or Amhr2-iCre(Fjd) driven by the Amhr2 promoter is active in the early embryo and can lead to global genetic modification, rendering this transgenic mouse model ineffective.Keywords
Funding Information
- NIH (Z1AES103311)
This publication has 25 references indexed in Scilit:
- Specific gene-regulation networks during the pre-implantation development of the pig embryo as revealed by deep sequencingBMC Genomics, 2014
- Stromal-to-Epithelial Transition during Postpartum Endometrial RegenerationPLOS ONE, 2012
- Cell-specific conditional deletion of Pten in the uterus results in differential phenotypesGynecologic Oncology, 2011
- Decidual PTEN expression is required for trophoblast invasion in the mouseAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Conditional Deletion of Beta-Catenin Mediated by Amhr2cre in Mice Causes Female Infertility1Biology of Reproduction, 2009
- Synergistic effects of Pten loss and WNT/CTNNB1 signaling pathway activation in ovarian granulosa cell tumor development and progressionCarcinogenesis, 2008
- Transcript profiling during preimplantation mouse developmentDevelopmental Biology, 2004
- Requirement of Bmpr1a for Müllerian duct regression during male sexual developmentNature Genetics, 2002
- Male development of chromosomally female mice transgenic for SryNature, 1991
- A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motifNature, 1990